Advancing the practice of Activity Based Therapy and Neuro-modulation for the Restoration of Upper Extremity Function after Spinal Cord Injury (ABT SCI Study) - Only 2 more subjects needed
The objective of the study is to clinically evaluate the effectiveness and implementation of an Activity Based Therapy (ABT) and neuromodulation (non-invasive spinal cord stimulation) for enhancing hand-arm strength and function in individuals with spinal cord injury. The ABT group will have 12 1.5-hour sessions of ABT over 4 weeks. The ABT with neuro-modulation group will have 28 2-hour sessions of Functional Task training with non-invasive spinal electrical stimulation over 10 weeks. Evaluations will consist of upper arm functionality and strength tests, along with assessing long-term consequences of spinal cord injury, including pain, spasticity, sleep, and bladder/bowel/sexual function (conducted once a month). Eligible participants must have traumatic or non-traumatic cervical spinal cord injury classified as AIS A to D and be at least 6 months post-incident, aged 18 years or above, and on stable spasticity and pain medications. They must also be able to actively participate in the training and assessment sessions throughout the study's duration.
Contact: Dr. Sukhvinder Kalsi-Ryan 416-597-3422 ext. 6340, sukhvinder.kalsi-ryan@uhn.ca
Upper extremity rehabilitation for new persistent C5 palsy in patients with degenerative cervical myelopathy (C-FIVE Study)- Currently Enrolling
The purpose of this study is to investigate the safety and effectiveness of combining functional electrical stimulation therapy (FES-t) with task-specific training, the current standard of care, to improve neurological and functional recovery, and connectivity and excitability in the ascending and descending neural pathways in individuals with persistent C5 palsy, even after conventional rehabilitative therapies.
The study involves 16 participants who will be randomly assigned to either receive conventional therapy alone or combined therapy (conventional and FES-t with task-specific training for the upper-extremity rehabilitation). Both groups will undergo physiotherapy for 1 hour per day, 4 to 5 days a week, for up to 10 weeks (30 sessions). The intervention group will additionally receive an hour of FES-t with task-specific training after the standard physiotherapy session on the same day, allowing the option for a 30-minute rest between the two sessions. The FES-t protocol will be tailored to each participant's abilities using a multichannel FES system (ie. MyndSearch™ device in development at KITE UHN) used during task-specific training. Eligible participants include adults aged 18 years or older with new unilateral or bilateral, persistent C5 palsy within 3 months after surgical treatment for degenerative cervical myelopathy and the ability to read and speak English.
Spinal Cord Stimulation for Walking in Incomplete Spinal Cord Injury - Currently Enrolling
This study looks at the benefits of spinal cord stimulation coupled with balance training, for individuals with incomplete spinal cord injury. Candidates can have traumatic or non-traumatic spinal cord injury and need to be at least one year post injury, with the ability to stand with assistance.
This study looks at the effects of sleep or lack of sleep on the well-being of individuals with spinal cord injury. Patients are enrolled while they are inpatients, and followed up to 6 months.
Effectiveness of Targeted Individualized Rehabilitation in Adults Suffering from Persistent Concussion Symptoms Compared to Usual Care: A Randomized Clinical Trial - Currently Enrolling
Patients who sustain a concussion and experience persistent symptoms beyond the normal healing time are among the more difficult cases to manage for even the most experienced clinician. Symptoms are non-specific and patients often fail to achieve a full recovery with standard forms of therapy. Current guidelines suggest treatments be individualized and target specific impairments; however, the lack of trials investigating rehabilitative interventions directed to patients’ physical symptoms is a considerable limitation. Aerobic exercise and multimodal rehabilitation have consistently shown to be a possibly effective means to manage this population; however, the optimal training prescription is unclear. To date, exercise has not been compared to anything but a stretching program and largely this intervention has only been applied to a young athletic population. Thus, there is a need to further examine the effectiveness of multimodal individualized rehabilitative treatments inclusive of an exercise program in a representative population.
Participants (n = 50) will be eligible for study participation if they meet the following inclusion criteria: 21 years and older; meet the definition of post-concussion syndrome as defined by Tator et al., and have adequate language skills in English to read and take part in the rehabilitation treatment programs.
Study Design: We will be conducting a 12-week case-crossover randomized controlled trial. Participants will undergo 6-weeks of care in their respective streams. After 6-weeks, participants will undergo a re-examination. They will then crossover and undertake the alternative treatment for 6 weeks. At the end of 12 weeks, participants will undertake the endpoint examinations. Participants will undergo a comprehensive clinical evaluation at the KITE research clinics to differentiate their post-concussive subgroup(s). Evaluation will consist of recommended elements of a standardized clinical physical examination outlined by Matuszaket al., inclusive of an exercise stress test via the Buffalo ConcussionTreadmill Test (BCTT). The BCTT has shown clinical utility in identifying those likely to suffer persistent symptoms and the test is an excellent guide for exercise prescription following a concussion
Advancing the practice of Activity Based Therapy and Neuro-modulation for the Restoration of Upper Extremity Function after Stroke (ABTStroke Study) - Currently Enrolling
The objective of the study is to clinically evaluate the effectiveness and implementation of an Activity Based Therapy (ABT) and neuromodulation (non-invasive spinal cord stimulation) for enhancing hand-arm strength and function in stroke survivors. The ABT group will have 121.5-hour sessions of ABT over 4 weeks. The ABT with neuro-modulation group will have 28 2-hour sessions of Functional Task training with non-invasive spinal electrical stimulation over 10 weeks. Evaluations will consist of upper arm functionality and strength tests, along with assessing long-term consequences of stroke. Eligible participants must have sustained a stroke, have an Arm stage of at least 2, and hand stage of at least 3, be at least 3 months post-stroke, aged 18 years or above, and on stable spasticity and pain medications. They must also be able to actively participate in the training and assessment sessions throughout the study's duration.
Contact: Dr. Sukhvinder Kalsi-Ryan 416-597-3422 ext. 6340, sukhvinder.kalsi-ryan@uhn.ca
Closed Studies
Point-of-care prediction of muscle responsiveness to functional electrical stimulation therapy (FES-T) (WfL Study)- Closed to enrollment
This study aims to develop a diagnostic method that enables therapists to efficiently assess muscles in a clinic and predict their responsiveness to functional electrical stimulation therapy (FES-T). The study involves 30 participants with cervical spinal cord injury and 5 participants with stroke, collaborating with a clinic providing FES-T. The muscles targeted for training will undergo a detailed electrophysiological examination before therapy initiation, followed by monitoring their strength recovery over 20-40 sessions. Lastly, signal processing and machine learning techniques will be applied to the electrophysiological data to predict the recovery profile of each muscle. Eligibility criteria include being at least 6 months post-injury for cervical SCI or 6 months post-stroke and meeting the criteria for upper limb FES-T as defined in the clinical operations of the KITE Clinics at TRI.
ARC UpLift Study. Onward Pivotal Trial
Transcutaneous Spinal Cord Stimulation (ARCEXTherapy) is Safe and Effective at Improving Upper Extremity Function Following Spinal Cord Injury
Objective: To determine the safety andeffectiveness of ARCEX Therapy delivered in the clinic and home setting.
Background: Cervical SCI leads to upper extremity (UE) impairment significantly altering quality of life. ARCEXTherapy, which combines transcutaneous spinal cord stimulation with functional task practice (FTP), may facilitate functional recovery in this population.
Methods: Sixty-five participants enrolled in a prospective, single-arm, multi-center trial (Up-LIFT, NCT04697472) that included a run-in period of two months of UE FTP, followed by an equivalent period ofARCEX Therapy, with stimulation delivered over the cervical spinal cord. Within12 months of completion of in-clinic ARCEX Therapy, seventeen individuals subsequently enrolled in one month of therapy delivered in the home setting with the aid of a caregiver (LIFT Home, NCT05284201). The primary safety end point for both trials reported device-related serious adverse events (SAEs).Effectiveness was evaluated utilizing a composite responder score to assess whether the majority of participants achieved clinically significant improvements in at least one strength (ISNCSCI-UEMS, GRASSP Strength, pinch and grasp force) and at least one function metric (CUE-T and GRASSP Prehension)during the ARCEX Therapy phase of the Up-LIFT Trial. Similar effectiveness outcomes were obtained during the LIFT Home Trial (excluding UEMS).
Results: No SAEs related to ARCEX Therapy were reported in any of the individuals who participated in clinic or home-based therapy. Of sixty participants who completed the in-clinic ARCEX Therapy phase,72% met the predefined primary effectiveness endpoint. CUE-T scores and pinch forces significantly improved following home-based therapy (Δ 2.2 ± 4.1,p=0.025 and Δ 6.9N ± 15.5, p=0.020, respectively). Compliance with the prescribed therapy at-home was high and mirrored in-clinic therapy dosages, with participants completing 12.3 ± 2.9 sessions.
The Portable Neurostimulator Brain Injury Treatment Program: A six patient Clinical Feasibility Study.
Investigators: S Kalsi-Ryan1,2, R D’Arcy3,4,5 H Condello6, C Chebaro2,7, J Vaughan-Graham2,8
Affiliations: 1 KITE Research Institute – University Health Network; 2 Department of Physical Therapy and Rehabilitation Sciences Institute, University of Toronto; 3 BrainNET, Applied SciencesSimon FraserUniversity; 4DM Centre for Brain Health, University of British Columbia; 5 Centre for NeurologyStudies, HealthTech Connex; 6 Complex Injury Rehab; 7 Neurocore Physiotherapy; 8 Physio-Logic Rehabilitation Services
Background: Although the majority of persons who suffer a mild TBI recover within a period of 10-14 days, recovery timelines are highly variable. An estimated 15-20% of persons affected by a mild TBI experience persisting symptoms affecting their ability to return to school, work and perform independent activities of daily living. Cranial nerve non-invasive neuromodulation (CN-NINM) has been shown to significantly improve balance and gait for those who suffer chronic balance deficits following mild-to-moderate TBI (mmTBI) and whom plateaued on prior conventional therapies.
Rationale: Unresolved gait and balance problems are common amongst persons with mmTBI. Understanding the benefits of CN-NINM in the treatment and resolution of balance and gait deficits in persons with mmTBI is essential in developing a clinically relevant evidence base . A clinical feasibility program was undertaken to gain a greater understanding through experience, the application, feasibility and outcome of aPoNS mmTBI program.
Methods: A pre-post design was used. All therapists and researchers involved in the delivery of the PoNS mmTBI program participated in an in-person 2day training program to become PoNS certified. Potential participants were referred from the community as well as TBI/concussion programs to the Principal investigator. All potential participants were screened, and, if eligible, were assessed by a neurosurgeon for review and clearance. On medical clearance the participant underwent baseline assessments. The PoNS mmTBI program was delivered via private community neuro-rehabilitation clinics in the greaterToronto area. All baseline and follow-up assessments were conducted by an independent assessor who was not blinded, but was not involved in the delivery of the treatment program. Six participants with mmTBI were recruited and enrolled to the study from January 2020 to February 2021. The PoNS mmTBI program was a 14 week physical therapy program coupled with PoNS stimulation. Outcome assessments were conducted prior to program initiation, at 2 weeks, 8 weeks and 14 weeks after program initiation.The primary outcome measure was the Community Balance and Mobility Scale(CB&M). Secondary outcome measures included the Functional Gait Assessment (FGA) and the NeuroCatch (N100, P300,& N400).
Results: Fourteen individuals were screened, 8 were eligible and 8completed baseline assessment. Two participants did not initiate the program; 6commenced the PoNS mmTBI program, 1 dropped out of the program at weeks 2 due to the intensity of the program. Mean (SD) change scores towards improvement for CB&M and FGA were 18 (11.2) and 6.2 (2.7) respectively. Examination of NeuroCatch results showed improvements in the speed of cognitive processing, as measured by the N400, within the group.
Conclusions: Individuals with persistent gait and balance deficits related to mmTBI demonstrated significant and clinically meaningful improvements in balance, gait and speed of cognitive processing following a PoNS mmTBI program.